Mast cell degranulator compound 48-80 promotes atherosclerotic plaque in apolipoprotein E knockout mice with perivascular common carotid collar placement

Chinese Medical Journal

Volumn 122, Issue 3, 2009, Pages 319-325

  Tang, Ya Ling ^a   Yang, Yong Zong ^a   Wang, Shuang ^a   Huang, Tao ^b   Tang, Chao Ke ^a   Xu, Zeng Xiang ^a   Sun, Yu Hui ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b Chinese People's Liberation Army No 95871 ^*  (China)

Author keywords

Atherosclerosis; Compound 48 80; Mast cells; Plaque

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; APOLIPOPROTEIN E; BASIC FIBROBLAST GROWTH FACTOR; COMPOUND 48-80; INTERLEUKIN 1BETA; MESSENGER RNA; TRYPTASE; VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY OBSTRUCTION; CELL PROLIFERATION; COMMON CAROTID ARTERY; CONTROLLED STUDY; ENZYME ACTIVITY; KNOCKOUT MOUSE; MACROPHAGE; MALE; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CAROTID ARTERIES; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MAST CELLS; MICE; MICE, KNOCKOUT; P-METHOXY-N-METHYLPHENETHYLAMINE;

EID: 62749159943     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.03.016     Document Type: Article

References (23)

1. Schwartz LB. Effector cells of anaphylaxis: mast cells and basophils. Novartis Found Symp 2004; 257: 65-74.
2. Côte CH, Tremblay MH, Duchesne E, Lapoite BM. Inflammation-induced leukocyte accumulation in injured skeletal muscle: role of mast cells. Muscle Nerve 2008; 37: 754-763.
3. Dileepan KN, Stechschulte DJ. Endothelial cell activation by mast cell mediators. Methods Mol Biol 2006; 315: 275-294.
4. Kovanen PT, Kaartinen M, Paavonen T. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 1995; 92: 1084-1088.
5. Lu C, Zhao FD, Li XB, Yin LH. Up regulation of interleukin-8 expressions induced by mast cell tryptase via protease activated receptor-2 in endothelial cell line. Chin Med J 2005; 118: 1900-1906.
6. Marshall JS. Mast-cell responses to pathogens. Nat Rev Immunol 2004; 4: 787-799.
7. Boyce JA. Eicosanoid mediators of mast cells:receptors, regulation of synthesis, and pathobiologic implications. Chem Immunol Allergy 2005; 87: 59-79.
8. Lindstedt KA, Leskinen MJ, Kovanen PT. Proteolysis of the pericellular matrix: a novel element determining cell survival and death in the pathogenesis of plaque erosion and rupture. Arterioscler Thromb Vasc Biol 2004; 24: 1350-1358.
9. Kaartinen M, Penttila A, Kovanen PT. Mast cells in rupture-prone areas of human coronary atheromas produce and store TNF-alpha. Circulation 1996; 94: 2787-2792.
10. Lappalainen H, Laine P, Pentikainen MO, Sajantila A, Kovanen PT. Mast cells in neovascularized human coronary plaques store and secrete basic fibroblast growth factor, a potent angiogenic mediator. Arterioscler- Thromb Vasc Biol 2004; 24: 1880-1885.
11. Zhang L, Yin HJ. Vulnerable plaque and internal atherosclerosis plaque angiogenesis. Chin J Interg Trad Western Med (Chin) 2007; 27: 1140-1143.
12. Leskinen MJ, Kovanen PT, Lindstedt KA. Regulation of smooth muscle cell growth, function and death in vitro by activated mast cells-a potential mechanism for the weakening and rupture of atherosclerotic plaques. Biochem Pharmacol 2003; 66: 1493-1498.
13. Leskinen MJ, Lindstedt KA, Wang Y, Kovanen PT. Mast,cell chymase induces smooth muscle cell apoptosis by a mechanism involving fibronectin degradation and disruption of focal adhesions. Arterioscler Thromb Vasc Biol 2003; 23: 238-243.
14. von der Thusen JH, van Berkel TJ, Biessen EA. Induction of rapid atherogenesis by perivascular carotid collar placement in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice. Circulation 2001; 103: 1164-1170.
15. Kelley JL, Chi DS, Abou Auda W, Smith JK, Krishnaswamy G The molecular role of mast cells in atherosclerotic cardiovascular disease. Mol Med Today 2000; 6: 304-308.
16. Lehtonen-Smeds EM, Mayranpaa M, Lindsberg PJ, Soinne L, Saimanen E, Jarvinen NA, et al. Carotid plaque mast cells associate with atherogenic senim lipids, high grade carotid stenosis and symptomatic carotid artery disease. Cerebrovasc Dis 2005; 19: 291-301.
17. Atkinson JB, Warlan, CW, Harlan GC, Virmani R. The association: of mast cells and atherosclerosis: a morphologic study of early atherosclerotic lesions in young people, Hum Pathol 1994; 125: 154-159.
18. Huckle WR, Earp HS. Regulatica of cell proliferation and growth by angiotensinII. Prog Growth Factor Res 1994; 5: 177-194.
19. Akasu M, Urata H, Kinoshita A, Sasaguri M, Ideishi M, Arakawa K. Differences in tissue angiotensin II-forming pathways by species arfd organs in vitro. Hypertension 1998; 32: 514-520.
20. Sluimer JC, Gasc JM, van Wanroij JL, Kisters N, Groeneweg M, Sollewijn Gelpke MD, et al. Hypoxia, hypoxia-indućible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis. J Am Coll Cardiol 2008; 51: 1258-1265.
21. Libby P, Warner SJ, Friedman GB. Interlukin1: a mitogen for human vascular smooth muscle cells that induces the release of growth inhibitory prostanoids. J Clin Invest 1998; 81: 487-498.
22. Blaif RJ, Meng H. Human mast cells stimulate vascular tube formation: tryptase is a novel, potent angiogenic factor. J Clin Invest 1997; 99: 2691-2700.
23. Gharavi NM, Baker NA, Mpuillesseaux KP, Yeung W, Honda HM, Hsieh X, et al. Role of endothelial nitric oxide synthase in the regulation of SREBP activation by oxidized phospholipids. Circ Res 2006; 98: 768-776.